AbSci Announces Strategic Investment

23 Feb, 2021

AbSci Announces Strategic Investment
Photo by Startaê Team on Unsplash

– AbSci announced a strategic equity investment by Merck Global Health Innovation Fund.
– Merck GHI is a fund of Merck Research Laboratories.
– AbSci is a leading synthetic biology company that translates ideas into drugs with a revolutionary platform technology that reinvents the biopharmaceutical drug discovery process.

Biopharma Biotechnology Life Science Machine Learning Manufacturing North America
Crunchbase icon

Content report

The following text will be sent to our editors: